Goldman Sachs Maintains Neutral Rating for LifeStance Health Gr: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Goldman Sachs has maintained a Neutral rating for LifeStance Health Group Inc (NASDAQ:LFST) but lowered its price target from $9.00 to $8.00. LifeStance Health's shares are currently trading at $6.10, down 0.97% over the last 24 hours. The new price target suggests a potential upside of 31.15% from the current share price. LifeStance Health provides outpatient mental health care services.

November 22, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Goldman Sachs maintains Neutral rating on LifeStance Health and lowers price target from $9 to $8. Current trading price is $6.10, indicating a potential 31.15% increase.
The maintenance of a Neutral rating by Goldman Sachs indicates no significant change in the company's outlook, but the reduction in price target could suggest a tempered expectation of future performance. However, the new target still represents a significant upside from the current trading price, which could be seen as a positive signal for investors. The short-term impact on the stock price may be limited as the rating remains unchanged, but the lower price target could cause some investors to adjust their expectations.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100